Previous 10 | Next 10 |
RedHill Biopharma to Present at H.C. Wainwright Annual Global Investment and Cantor Global Healthcare Conferences TEL AVIV, ISRAEL and RALEIGH, NC / ACCESSWIRE / September 2, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical compan...
RedHill Biopharma to Present at H.C. Wainwright Annual Global Investment and Cantor Global Healthcare Conferences PR Newswire TEL AVIV, Israel and RALEIGH, NC , Sept. 2, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company...
Are These The Top Health Care Stocks To Watch This Week? While investors look for up-and-coming stocks in the stock market now, health care stocks continue to shine. After all, this sector of the market is home to countless companies looking to improve our overall quality of...
Shares of RedHill Biopharma (NASDAQ: RDHL) are on the move after Cantor Fitzgerald initiated coverage of the biopharmaceutical company. Investors excited about the buy rating have pushed the stock 20.3% higher as of 3:15 p.m. EDT on Tuesday. RedHill Biopharma has three drugs on ...
Gainers: AFRM +32.4%. MNTS +11.8%. KPLT +10.5%. VECT +5.2%. OSUR +3.9%. Losers: TSP -10.6%. LTCH -6.8%. LTRPA -4.8%. ENVX -4.3%. RDHL -3.2%. For further details see: AFRM, MNTS, TSP and LTCH among after hours movers
RedHill Biopharma Ltd. (RDHL) Q2 2021 Earnings Conference Call August 26, 2021 8:30 AM ET Company Participants Alexandra Okmian - Senior Business Development and Investor Relations Manager Dror Ben-Asher - Chief Executive Officer Guy Goldberg - Chief Business Officer Gilead Raday - Chief Oper...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re back at it again today as we start off another beautiful morning with a dive into Thursday’s pre-market stock movers. Source: f11photo/Shutterstock.com There’s plenty...
Achieved record quarterly revenues of $21.5 million for Q2/2021, 4.5% increase from Q1/2021 despite challenging market conditions; Cash balance [1] of approximately $71.5 million as of June 30, 2021 Record Talicia® quarterly prescription volume up more than 10%; Movantik ...
RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights - Achieved record quarterly revenues of $21.5 million for Q2/2021, 4.5% increase from Q1/2021 despite challenging market conditions; Cash balance1 of approximately $71.5 million as of June...
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cells model, adding to prior data demonstrating potent inhibition of all COVID-19 variants tested to da...
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
Redhill Biopharma Ltd. Website:
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 22, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biophar...
RedHill Biopharma Terminates License Agreement for Aemcolo® PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 9, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today ...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...